Extranodal Nasal NK/T Cell Lymphoma - 24 Studies Found

Completed : Gemcitabine in NK/T Cell Lymphoma
: NK/T Cell Lymphoma
: 2012-08-06
Completed : Radiotherapy Followed by Adjuvant Chemotherapy in NK/T-cell Lymphoma
: Extranodal NK/T-cell Lymphoma, Nasal Type
: 2012-08-13
: Drug: Radiotherapy followed by chemotherapy Radiotherapy Technique: IMRT Total dose: 50 Gy Per fraction:
Completed : Avastin+ GemAOD As First-Line Treatment in NK/T Cell Lymphoma
: Extranodal NK/T-cell Lymphoma, Nasal Type
: 2013-08-03
:
  • Biological: Avastin Avastin 7.
Active, not recruiting : GAD-M Regimen As First-Line Treatment in Untreated Extranodal NK/T Cell Lymphoma
: Extranodal NK/T-cell Lymphoma, Nasal Type
: 2013-11-07
:
  • Drug: High dose of methotrexate

Terminated : Radiotherapy Alone Versus Concurrent Chemoradiation in Low Risk NK/T-cell Lymphoma
: Extranodal NK/T-cell Lymphoma, Nasal Type
: 2012-08-13
:
  • Radiation: Radiotherapy alone

Completed : Retrospective Analysis of Skin/Soft Tissue Primary NK/T Cell Lymphoma
: Extranodal NK/T Cell Lymphoma
: 2011-04-21
Completed : International Extranodal NK/T-cell Lymphoma Project
: Extranodal NK/T-cell Lymphoma, Nasal Type
: 2015-03-06
Active, not recruiting : Pegaspargase and Methotrexate Based Regimens for Newly Diagnosed Extranodal NK/T Cell Lymphoma
: Nasal Type Extranodal NK/T-Cell Lymphoma
: 2015-11-22
:
  • Drug: Pegaspargase
  • Drug: Methotrexate
Active, not recruiting : Concomitant Chemo-radiotherapy Plus VIDL Chemotherapy in NK/T-cell Lymphoma
: Stage I/II Extranodal NK/T-cell Lymphoma
: 2009-11-02
: Other: concomitant chemo-radiotherapy followed by VIDL chemotherapy with risk-based application of autologous stem cell transplantation
Not yet recruiting : Mild-dose IMRT for Early-staged Extranodal Nasal-type NK/T-cell Lymphoma With CR Tumor After GELOX Chemotherapy
:
  • Lymphoma,
  • Non-Hodgkin Lymphoma,
  • Extranodal